FinnCap Reiterates “Corporate” Rating for Avacta Group (AVCT)

FinnCap reissued their corporate rating on shares of Avacta Group (LON:AVCT) in a report published on Tuesday, April 9th, ThisIsMoney.Co.Uk reports.

LON:AVCT traded down GBX 1.25 ($0.02) during mid-day trading on Tuesday, hitting GBX 30.25 ($0.40). 313,685 shares of the company traded hands, compared to its average volume of 19,964. The firm has a market capitalization of $34.16 million and a PE ratio of -2.61. Avacta Group has a one year low of GBX 21 ($0.27) and a one year high of GBX 51 ($0.67).

Avacta Group (LON:AVCT) last released its quarterly earnings data on Tuesday, April 9th. The biotechnology company reported GBX (4.80) (($0.06)) earnings per share for the quarter. On average, equities analysts anticipate that Avacta Group will post -11.0499998747087 earnings per share for the current year.

Avacta Group Company Profile

Avacta Group Plc offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. It operates through two segments, Life Sciences and Animal Health. The company's custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

See Also: What is the Ex-Dividend Date in Investing?

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.